US Generics Market Continues To Seek Stability

Firms Adopt Varying Strategies To Ride Out Ongoing Turbulence In The US

As the US generics market continues to experience turbulence, the industry’s largest players are adopting a wide range of strategies to cope with the uncertainty as signs of stabilization begin to emerge.

IV1912_Generics_Pricing-Pressure_413035387_1200.jpg
Pricing Pressure Continues In Generics Market

At the start of 2019, the chief executive of one of the generics industry’s biggest players set out a bold claim: that the severe US pricing pressures experienced over the past few years had stabilized, bringing an end to a period of misery for many generics producers.

“The whole pricing dynamic in US generics [has] changed,” Teva Pharmaceutical Industries Ltd. president and chief executive officer Kåre...

More from Market Intelligence

More from In Vivo